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ABSTRACT 
The purpose of this project was to review the effects of dietary supplements on 
degenerative ocular tissue changes. Early evidence established roles of dietary essential 
vitamins and minerals based on of gross deficiency symptoms which respond to 
supplementation. Ocular tissue changes resulting from specific vitamin or mineral 
deficiencies are numerous and include corneal neovascularization, opacification and 
ulceration, secretory cell production, blepharitis, papilledema, retinal edema, cataracts 
and night blindness. Recent research suggests uncontrolled oxidation reactions 
initiated by free radical formation may produce significant tissue damage including 
macular degeneration and cataract formation. The antioxidant activities of vitamins C 
and E, and the mineral zinc demonstrate interesting potential as dietary supplements 
for prevention and possible treatment of these conditions . In addition, b-carotene, 
taurine, glutathione, superoxide dismutase and a lesser known class of compounds 
known as flavinoids also show antioxidant activity and potential for dietary 
supplementation. Continued investigation is needed to prove the efficacy of each. 
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INTRODUCTION 
The role of vitamins, minerals and other oral nutritional supplements 
have received considerable attention. Some of the attention is due to a thriving 
interest in either a natural means of bodily repair or an alternative pharmaceutical 
approach to health that is less subject to strict FDA control. Others seek a means to 
deal with ocular tissue changes such as cataracts and age related macular 
degeneration (ARMD). These are two conditions that at present have no cure. 
Surgical intervention represents the only accepted alternative to these visually 
debilitating conditions. 
There has been a considerable increase in consumption of commercially 
available vitamin/mineral supplements over the past decade. According to a 
recent U.S. National Health Interview Survey, over 30'X, of all adults in the United 
States use vitamin and/or mineral supplements . Interestingly, consumption 
tends to fall within families that typically have adequate dietary supplies of 
essential vitamins and minerals and supplementation in this group approaches 
potentially toxic levels.l 
Research on the roles of many elements required for normal metabolic 
activity of the eye has been numerous. Many questions regarding the efficacy of 
dietary supplements remain unanswered. The importance of an adequate supply 
of the common dietary vitamins and minerals to normal growth and metabolism 
is well known. However, specific roles of these elements, including many lesser 
known compounds in diseased or aging eye tissue is not clearly understood. Many 
claims concerning the effects of supplemental vitamins/minerals are substantiated 
by poorly designed and documented studies . However, advocates of these less 
orthodox means for ocular disease management and treatment continue to 
vocalize success. Much work remains to verify the results of "pilot" studies and 
1 
case reports that often claim significant results. The visual system is composed of 
several tissue types including epitheliat nervous, osteoid, blood and muscle. This 
tissue variety implicates many possible roles for supplemental nutrients. The 
purpose of this paper is to document evidence for the use of nutritional 
supplements in the maintaining healthy ocular tissues. Their role in prevention 
and treatment of degenerative ocular tissue changes associated with development, 
ageing, trauma and predisposing systemic conditions will be described. 
2 
FREE RADICAL CHEMISTRY 
The traditional roles of vitamins and minerals have been accepted for many 
years including those specifically associated with eye function. Recently, 
researchers have developed techniques for examining the destructive action of 
free radicals in the eye. They are also engaged in defining the roles of substances 
with antioxidant properties as a source of natural protection to affected tissues. 
Evidence suggests antioxidants play a significant role in retarding degenerative 
tissue changes caused by free radicals including damage to such tissues as the aging 
lens and retina. Age related macular degeneration (ARMD) and cataract formation 
are two of the most common vision impairments of the elderly. Both diseases 
involve free radical activity . Currently, only wet ARMD has any treatment and 
cataract surgeries are routinely performed on an outpatient basis but only after a 
considerable period of vision impairment on selected patients. An overview of 
free radicals and antioxidants is key to understanding the potential behind 
nutritional intervention.The promise of preventive and alternative treatment 
measures has immense value and the role of vitamins and minerals as a 
nutritional approach to prevention and treatment is under active investigation. 
A free radical (FR) is any molecule that contains one or more unpaired 
electrons in its outer orbital. These molecules achieve this status by either gaining 
an electron or by losing one. The following list includes potentially cytotoxic 
species of oxygen. 2 
In biological systems, oxygen free radicals are responsible for many effects 
and they occur in primarily two forms : 1) superoxide anion formed by adding one 
electron to molecular oxygen, 2) singlet oxygen produced by reversing the spin of 
one electron in the outer orbit. A complete explanation of superoxide chemistry is 
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beyond the scope of this text but its activity is very dependant upon whether is 
resides in an aqueous or an organic environment. 
or 
H02 
H202 
OH 
ROO 
1o2 
Cytotoxic Species of Oxygen 
Superoxide anion radical 
Hydroperoxyl radical 
Hydrogen Peroxide 
Hydroxyl radical 
Peroxide radical 
Singlet oxygen 
The superoxide free radical is the key player in the "superoxide theory of 
oxygen toxicity" which was developed after the discovery of the enzyme 
superoxide dismutase. This enzyme specifically catalyzes the removal of the 
superoxide radical 02-. The production of significant amounts of the superoxide 
radical has been difficult to prove. And, it is not especially cytotoxic since it is most 
destructive when converted into either hydrogen peroxide or a hydroxyl radical. 
Hydrogen peroxide is not especially toxic to cells either but it can cross cell 
membranes into the extracellular environment where few antioxidant 
mechanisms are not present. Hydrogen peroxide becomes more dangerous in the 
presence of transition metals such as iron and copper ions which can give rise 
hydroxyl radicals. The superoxide anion can also react with hydrogen peroxide 
giving rise to the hydroxyl radical. The hydroxyl radical is the most injurious 
specie and is capable of reacting with nearly any molecule in its vicinity. It can 
initiate protein damage, DNA breakage and lipid peroxidation. The high 
concentration of fatty acids in the cell membrane lipid bilayer is fertile ground for 
free radical induced chain reactions resulting in fatty acid peroxy free radicals. The 
end products of lipid peroxidation are aldehydes, hydrocarbon gases and various 
chemical residues that diffuse away from the reaction site Once these end products 
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leave the reaction site they can cause cell edema, changes in vascular permeability, 
inflammation and chemotaxis. Aldehydes also cross link lipids with proteins 
resulting in aggregates that cannot be digested and accumulate as lipofuscin in the 
eye.2,3,4 
Singlet oxygen is the product of photosensitized molecules such as 
rhodopsin which release energy after exposure to appropriate wavelengths of light. 
The release of energy as it returns from the excited to the ground state is 
transferred to an adjacent oxygen molecule and 102 results.4 One of two reactions 
will result after singlet oxygen is produced. The oxygen may combine with 
another molecule, including rhodopsin. Or, it releases its energy to another 
molecule, such as ascorbate or carotene, which are known as a singlet oxygen 
"quenchers". 
Most free radicals are the result of normal redox reactions within the body. 
However, significant damage is done when they are produced in excess or when 
protective antioxidant systems are impaired. Light of appropriate wavelengths 
have been shown to cause photolysis of chemical bonds resulting in free radical 
production. Exposure of the retina to higher energy radiation in the short visible 
to ultraviolet wavelengths can create photochemical damage when the energy 
supplied is equal to the difference between the ground state and the excited state of 
outer orbital electrons. An electron that returns from the excited state to the 
ground state releases its energy in various ways, including electron transfer to 
molecular oxygen which can produce the superoxide free radical or singlet oxygen. 
As mentioned above, lipid peroxidation occurs which yields residual bodies of 
lipofuscin if this process occurs in the retina.3 The outer layers of the retina 
containing the rods and cones are uniquely susceptible to this degenerative process 
due to the high concentrations of oxygen and fatty acids. Free radical sources in 
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addition to radiation include ozone, cigarette smoke, pesticides and anesthetics. 
Their overall contribution to tissue damage is undetermined. 
The body has a natural defense system against free radical damage. 
Superoxide dismutase enzymes prevent the conversion of hydrogen peroxide to 
the hydroxyl radical. Hydrogen peroxide reacts with reduced glutathione to 
produce oxidized glutathione and water. Glutathione peroxidase catalyzes lipid 
peroxide reduction and thus reducing lipid peroxidation. Tissue levels of vitamin 
E is a lipid phase antioxidant capable of converting superperoxide anion, hydroxyl 
and lipid peroxyl radicals to less reactive forms . Vitamin C is an aqueous phase 
antioxidant. Cysteine has the ability to quench free radicals and ceruloplasmin can 
act as an extracellular antioxidant) B-carotene has also been shown to have 
antioxidant role in tissues . Bilirubin, uric ocid, glutathione and catalase also act as 
antioxidants.S Antioxidant roles for selenium, zinc, copper and vitamins A, C, 
and E also exist. These will be discussed later. 
6 
VITAMINS 
The eye is a complex organ. It is composed of several tissue types including 
epithelial, collagen and nervous tissue. It is also a highly vascular structure. 
These characteristics make the eye subject to many conditions that by gross 
inspection might seem only to affect larger parts of the body. Recognizing the 
comlexity of its structure and function will help place the role of nutrition in a 
proper perspective. The table below lists general functions of several vitamins. 
Note that the eye is either directly or indirectly affected by each. 
Vitamin 
A 
Bl(Thiamin) 
Vitamins 
Function 
Regeneration of rhodopsin 
Nerve activity 
CHO metabolism 
B2(Riboflavin) Coenzyme, affects vision 
B6(Pyridoxine) Fatty acid metabolism 
B7(Biotin) 
c 
E 
K 
Growth factor, affects skin 
Reducing agent, cholesterol 
metabolism 
Antioxidant: cofactor between 
cytochromes b and c 
Prothrombin synthesis 
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Deficiency Effects 
Excessive light sensitivity, 
nightblindness, increased 
susceptibility to infection 
Beriberi, nervous disorders, 
muscular atrophy, circulatory 
disorders 
Lip sores, burning eyes, 
light sensitivity 
Anemia, luecocytosis, eye, 
nose and mouth lesions 
Scaly, greasy skin 
Hemorrhages, mouth lesions, 
scurvy, muscle degeneration 
Sterility 
Hemorrhage, slow blood clotting 
Vitamins play a significant role in the health of all bodily tissues. The eye 
consists of several sensitive tissues that show signs of dysfunction when normal 
metabolism is disrupted by deficiency or when tissue stress increases the demand 
beyond normal requirements . The following vitamins play key roles in tissue 
metabolism of the eye. 
Vitamin A 
Carotenoids of plants represent the ultimate source of vitamin A (retinol), 
with B-carotene being the most important precursor. B-carotene is converted to 
retinol by the intestinal mucosa, absorbed as a retinyl ester and combined with 
retinol-binding protein prior to transport to receptive tissues . Once in the tissues 
its primary biochemical role involves i ts interaction in the photoreceptor rods and 
cones . Exposure to light converts opsin bound 11-cis retinol to all-trans retinol. 
The resulting changes in ion transport and membrane potentials produce nerve 
impulses perceived as vision by the visual cortex6 The role of vitamin A in other 
ocular tissues has also undergone exhaustive research and the production of 
deficiency symptoms is a common method of determining function. Animal 
studies provide much of the evidence but several deficiency symptoms have been 
documented in the human. 
Animal studies show generalized lid and conjuctival inflammation associated 
with atrophy of secretory epithelial cells of the paraocular glands ( Meibomian, 
lacrimal, Harderian) in the rat. The resulting dryness or "xerosis" of the conjunctiva 
and cornea is accompanied by keratinization of the corneal epithelium, 
vascularization and cellular infiltrates. This can lead to secondary infection causing 
corneal ulceration and keratomalacia? Likewise, the posterior pole in animal studies 
demonstrates the need for vitamin A. Nightblindness has been a well known sign of 
avitiminosis and leads to suppression of the b- wave in the ERG in vitamin A 
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deficient rats. The progression of retinal degeneration in the rat was shown to begin 
with the rods and cones and move in order to the outer nuclear layer, retinal 
pigment epithelium, outer molecular layer and finally the inner molecular layer. 
There is some evidence in rabbits and calves that vitamin A plays a role in the 
metabolism of cerebrospinal fluid . Vitamin A deficient rabbits produce litters with a 
high incidence of hydrocephalus. Similarly, calves maintained on diets with low 
levels of B-carotene have increased cerebrospinal fluid pressures which caused 
symptoms of incoordination, syncope and papilledema? 
Human evidence for vitamin A deficiency also known as xerophthalmia, 
has several symptoms that fall into the following standardized classifications: 
Primary 
Conjunctival xerosis 
Bitot's spots 
Corneal xerosis 
Corneal ulceration with xerosis 
Keratomalacia 
Secondary 
Night blindness 
Xerophthalmia fundus 
Corneal scars 
Xerosis of the conjunctiva is characterized by decreased transparency, 
thickening and wrinkling. Poor tear wettability is another characteristic resulting 
from keratinization of superficial epithelium and decreased goblet cell secretion? 
Bitot's spots consist of raised, silvery-gray compact tissue mass with a foamy 
surface. They are superficiat occasionally pigmented and remain confined to the 
conjunctival epithelium. They are more common in vitamin A deficient males 
and do not interfere with vision? 
Xerosis of the cornea is characterized by punctate epithelial keratopathy. 
Occasionally stromal infiltrates and neovascularization contribute to its hazy 
appearance. Ulceration describes the partial to full thickness cell loss of the cornea 
with scarring evident once Bowmnn 's membrane has been compromised? 
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Keratomalacia describes a full thickness melting of the cornea into a 
gelatinous mass that generally precedes endophthalmitis or panophthalmitis if 
untreated. Again, this condition is predisposed by a dry cornea due to a vitamin A 
induced decrease in goblet cell secretion? 
Xerophthalmia fundus is described by general" pallor and faint white spots in 
the horizontal meridian and this is accompanied by night blindness?,8 The 
etiology of the white spots is unknown. 
The above symptoms respond well to vitamin A supplementation as 
reported by Djunaedi etal.9 whose distribution of vitamin A lowered the 
incidence of xerophthalmia among Indonesian preschool children. This study 
used presence of Bitot's Spots as a measure of the incidence of vitamin A 
deficiency. Semba etal.lO recently reported that vitamin A did not cure Bitot's 
Spots in 13lX, of the preschool children in his study. Typical management of 
xerophthalmia begins with restitution of normal vitamin A nutriture. Patients 
should receive 200,000 IU of oral retinyl palmitate on successive days with a third 
dose 1 to 4 weeks later, to replenish liver stores. Infants receive half this amount. 
Night blindness, xerosis and corneal ulceration respond within three days. Some 
extreme cases of malabsorbtion require 100,000 IU of water miscible retinyl 
palmitate to in sure initial adequate dosage (50,000 IU for infant). 11 These studies 
did not investigate the response of xerophthalmia fundus to vitamin A 
supplementation but O'Donnell and Talbot reported decrease incidence of grey-
white fundus spots, normalized b-wave amplitude with ERG trials and an 
improved Arden index following vitamin A treatment.8 
Other recent findings document additional benefits to ocular health 
supported by adequate levels of vitamin A. Vitamin A appears to reduce the 
inflammatory response associated with corneal epithelial wound healing. This 
was reported by Hayashi et al. who found vitamin A deficient rat corneas had 
l 0 
acute stromal inflammatory response secondary to epithelial wounds.12 Hayashi 
et al. also showed that vitamin A deficiency causes a decline in corneal epithelial 
energy metabolism by affecting creatine kinase activation.l3 
The role of vitamin A on mucus membrane integrity was demonstrated in 
a patient suffering from squamous metaplasia and keratinization of the tarsal 
conjunctiva accompanied by a chronic subconjunctival inflammatory infiltrate. 
When the metaplasia returned following excision, treatment with 0.05% retinoic 
acid lead to complete resolution. Normal conjunctiva consists of nonkeratinizing 
stratified squamous epithelium containing goblet cells. The change to keratinized 
epithelium, also called squamous metaplasia, can be caused by cicatrizing 
conjunctivitis, keratoconjunctivitis sicca and conjunctival dysplasia, topical drug 
therapy, ocular irradiation and chronic infection.l4 
Topical retinoic acid was also shown to increase endothelial cell migration 
and subsequent wound healing in rabbits according to a study by Matsuda etat15 
The role of vitamin A and its importance to the corneal epithelial barrier 
when considering the actions of opportunistic pathogens such a Psuedomonas is 
well defined. Its deficiency has been associated with increased severity of herpetic 
keratitis but conflicting results were reported by Hatchell etat16 
1 1 
The following dietary allowances for vitamin A are recommended by the 
Food and Nutrition Board of the National Research Council.17 
Retinol International 
Age Equivalents Units 
0-6 mos. 420 2100 
6-12 mos. 400 2100 
1-3 yrs. 400 2000 
4-6 yrs. 500 2500 
7-10 yrs. 700 3300 
Males 
11 + yrs. 1000 5000 
Females 
11 + yrs. 800 4000 
Pregnant +200 +1000 
Lactating +400 +2000 
Consultation with a physician is recommended if a patient has diabetes, 
kidney, liver or pancreas dysfunction, cystic fibrosis, hyperthyroid, intestinal 
disease with diarrhea Evidence clearly supports appropriate supplementation of 
vitamin A . It is also important to recall that although vitamin A is a 
nonprescription drug, chronic ingestion of high doses can be toxic. Toxicity 
typically develops after several months of intake ranging from 50,000 to 300,000 
IU I day. Hypervitaminosis A is characterized by headache, nausea, diplopia, 
blurred vision and papilledema with secondary optic atrophy.l8 Vitamin A is 
available in tablets, extended-release capsules and in oral solutions. 
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Vitamins of the B Complex 
Vitamins of the B complex are water soluble and include thiamine (Bl), 
riboflavin (B2), pyridoxine (B6), pantothentic acid, niacin, biotin, folic acid, insitol, 
choline and cobalamin (B12) . Like other essential vitamins, they are not 
synthesized by the body and dietary intake is required to maintain normal 
metabolism. Each is closely involved in carbohydrate, fat or protein metabolism. 
Animal studies have identified several roles for the B vitamins. A healthy 
conjunctiva and cornea depend on adequate vitamin B complex. A sign of 
riboflavin deficiency is corneal neovascularization which has been documented in 
several species including the rat, rabbit and dog. Pyridoxine, pantothenic acid and 
biotin deficiencies have also been documented causes of corneal 
neovascularization. Biotin deficiency in the rat has resulted in corneal 
ulceration. 7 
Maintenance of healthy lens tissue is dependent on adequate levels of 
riboflavin. Cataract development has been reported in the riboflavin deficient rat 
and monkey. Riboflavin deficiency has also caused degeneration of retinal 
ganglion cells in the rabbit leading to a depressed a/b wave amplitude ratio of the 
ERG. Folic acid and choline deficiencies are implicated in retinal vessel dilation 
and hemorrhage. The optic tract appears to be spmed from a dependence on 
essential B vitamins but there is limited evidence of optic tract degeneration in the 
thiamine/riboflavin deficient rat. Choline has been implicated in maintenance 
endothelial cells in the iris, ciliary body and choroid. Intraocular hemorrhage has 
been found in choline deficient rats that also demonstrated kidney dysfunction 
and hypertension? 
Human studies show riboflavin d eficiency is the only B vitamin associated 
with corneal neovascularization which is characteristically found in all quadrants 
of the cornea. Circumcorneal injection, superficial punctate keratitis and nebulae 
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have also resulted from B2 deficiency and each responds well to riboflavin 
therapy. Angular blepharitis with occasional conjunctivitis has been noted in 
riboflavin deficient patients with some evidence suggesting pyridoxine deficiency 
is involved. 
The following daily allowances of B complex vitamins are recommended by 
the Food and Nutrition Board of the National Research Council )7 
Age B1 1 B2 
0-6 mos. 0.3 0.4 
6-12 mos. 0.5 0.6 
1-3 yrs. 0.7 0.8 
4-6 yrs. 0.9 1.0 
7-10 yrs . 1.2 1.4 
Males 
11-18 yrs. 1.4 1.6 
19-22 yrs . 1.5 1.7 
23-50 yrs . 1.4 1.6 
Females 
11-22 yrs . 1.1 1.3 
23+yrs. 1.0 1.2 
Pregnant +0.4 +0.3 
Lactating +0.5 +0.5 
B3 
6 
8 
9 
11 
16 
18 
19 
18 
15 
13 
+2 
+4 
B6 
0.3 
0.6 
0.9 
1.3 
1.8 
2.2 
2.0 
+0.6 
+0.5 
B12 H2 
0.5 35 
1.5 50 
2.0 65 
2.5 85 
3.0 120 
3.0 100-200 
3.0 100-200 
3.0 100-200 
3.0 100-200 
3.0 100-200 
4.0 100-200 
4.0 100-200 
1. All values are mg., except for B12 which is meg. 2. No RDA is set for 
vitamin H (Biotin) so the estimated daily safe intake is shown. 
Vitamin B12 complex supplementation has been shown to improve visual 
acuity in diagnosed cases of tobacco and alcohol amblyopia. Visual disturbances 
caused by retrobulbar neuropathy associated with chronic alcoholism respond well 
during early stages to thiamine. The etiology of nutritional amblyopia is not clear 
but most investigators would agree that the B complex is involved. Decreased 
visual acuity, central scotoma and extraocular muscle palsy has been found in 
1 4 
patients suffering from retrobulbar neuropathy secondary to pernicious anaemia. 
Early treatment with vitamin B12 will return vision to normal. Flame shaped 
hemorrhages, Roth spots, peripheral capillary microaneurysms, retinal edema and 
papilledema have also been found in patients afflicted with pernicious anemia 
(B12 deficiency). Wernicke-Krsakoff Syndrome results from an acute thiamine 
deficiency and is characterized by the following ocular signs: nystagmus, lateral 
rectus fatigue, decreased visual acuity, papilledema, ptosis and retinal hemorrhage. 
Nicotinic acid deficiency produces similar effects varying from bilateral nystagmus 
to complete ophthalmoplegia. 
Limited evidence suggests riboflavin deficiency can impair dark adaptation? 
Riboflavin is a precursor for flavin adenine dinucleotide (FAD) synthesis which is a 
cofactor for glutathione reductase. Glutathione reductase is an enzyme involved in 
lens metabolism. Evidence suggests the metabolic status of a cataractous lens may 
increase the demand for riboflavin as well as thiamine and pyridoxine.l9,20 
Pyridoxine has also been shown to decrease the chorioretinal atrophy associated 
with gyrate atrophy but not all investigators agree. 21 Intravenous pyridoxine has 
been found effective against chorioretinitis associated isoniazid treatment of 
tuberculosis. 22 
The B vitamins are available in tablets, timed release capsules, oral 
solutions and injectables. Overdose or toxicity symptoms for the B vitamins 
include nausea, vomiting and dark urine. 
Contraindications for their use include allergic responses, impaired liver or 
kidney function, peptic ulcer, gout, sensory neuropathy including unsteady gait 
and numb hands and feet. Pyridoxine may prevent the control of Parkinson's 
symptoms by levodopa.17 
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Vitamin C 
An ocular role for ascorbic acid or vitamin C as it is commonly known has 
been a subject of some controversy. Vitamin C is an essential vitamin with high 
concentrations in the aqueous, lens and vitreous. Despite this fact, its deficiency 
has shown few side effects. Early studies indicated vitamin C deficiency had little 
affect on lenticular metabolism and large doses of vitamin C had no effect on 
cataract development in both man and animals. Notable decreases in vitamin C 
have been documented in cataractous and ageing, nuclear lens tissue. Vitamin C 
acts as a cofactor for the enzymes proline and lysine hydroxylase which are 
involved in collagen synthesis. AlthoLLgh collagen formation is affected by 
vitamin C deficiency in other parts of the body, there seems to be little or no effect 
on the corneal stroma.4,7 
More recent findings indicate ascorbate acts as an antioxidant, being oxidized 
by free radicals produced in the neuroretina of rats following excessive light 
exposure. It appears to reduce the loss of rhodopsin following photic exposure 
which suggests a protective role.23 Supplementation has been shown to increase 
ascorbic acid levels in the retina and retinal pigment epithelium of the rat. These 
increases in ascorbic acid levels decrease hydrogen peroxide formation resulting 
from bright light exposure.24,25,26 High concentrations of ascorbic acid in the 
outer segment of photoreceptor cells in rats seems to quench the action of singlet 
oxygen produced by radiant energy absorption by the retina.24,27 The term 
'scurvy' describes the systemic condition of ascorbic acid deficiency. Ageing and 
smoking are often associated with subclinical forms of scurvy and both factors 
correlate highly with the development of various forms of macular 
degeneration.23 Todd reports vitamin C and bioflavinoid supplements aids the 
resolution of central serous retinopathy.28 
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Ascorbate appears to have a protective role against oxidative stress in the 
lens. Ascorbate reacts quickly with the superoxide radical and the hydroxyl radical. 
It is also a quencher of singlet oxygen. Ascorbate concentrations in the human 
lens are high while superoxide dismutase is low.4 Oxidative insult to the lens can 
arise from three sources: 1) normal metabolic activity, 2)ultraviolet light exposure 
and 3) hydrogen peroxide found in the aqueous. Ascorbic acid levels are known to 
decline in the ageing lens and the senile cataractous lens.29 Oxidative stress is 
believed to cause or accompany the development of nuclear and cortical cataracts. 
Hence, ascorbate could well have a protective role in the lens against oxidative 
damage. Evidence, though limited, suggests ascorbate supplementation could 
decrease the risk of cataract development presumably via the mechanism above.30 
The following daily allowances of ascorbic acid are recommended by 
National Research Councit17 
Age 
0-12 mos. 
1-10 yrs. 
11-14 yrs. 
15+ yrs. 
Pregnant 
Lactating 
RDA 
35 
45 
50 
60 
+20 
+40 
1. Units are in mg. 
A single study by Paterson et al. found ascorbic acid concentrations in the 
tear film were significantly higher than plasma levels. They suggested it may play 
an antioxidant role in the protection of the corneal surface, noting that activated 
PMN's present during inflammatory periods are an important source of toxic free 
radicals.31 
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In contrast to the potential benefits of ascorbate to lens tissue, Bron and 
Brown identified a correlation between ascorbate and calcium oxalate retrodots 
which are a common early cataractous change found in lens tissue. They propose 
ascorbate as the source of these retrodots . In addition, it was reported that toxic 
doses of vitamin C can lead to macular pucker and cellophane retinopathy. 29 
Adverse side effects from toxic overdose of ascorbic acid include anemia, 
flushed face, headache, increased urination, lower abdominal cramps, mild 
diarrhea, nausea and vomiting.l7 
Vitamin E 
A-Tocopherol, commonly known as vitamin E, is an essential fat soluble 
vitamin with a number of systemic deficiency symptoms in animals. In humans 
no specific deficiency diseases exist. There is some evidence for hemolytic anemia 
in low birth weight infants deficient in vitamin E. The hydrophobic nature of 
tocopherol allows it to concentrate on the inner membrane of cells, especially in 
the outer segments of the retinal rod cells. Blood lipoproteins also have high 
concentrations of tocopherol and this compound is the only major lipid soluble 
antioxidant in blood plasma.4 
The major role of vitamin E seems to be the prevention of lipid 
peroxidation since is has been shown to quench singlet oxygen. A-tocopherol can 
react with lipid peroxy radicals to form vitamin E radicals that will not oxidize 
membrane lipids. Vitamin C reduces tocopherol radicals back to tocopherol. 
Animals on diets high in polyunsaturated fats which encourage peroxidation 
reactions show increased demand for supplemental vitamin E.4,32 
The antioxidant function of tocopherol appears to play an important role in 
maintaining normal ocular tissue function and metabolism. Investigation has 
shown vitamin E reduces the severity of retrolental fibroplasia in premature 
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infants who require high oxygen environments for early survival.4 A study in 
primates demonstrated macular degeneration in monkeys fed a vitamin E 
deficient diet for two year. Degenerative tissue changes were characterized by focal 
disruptions of photoreceptor cells. These disruptions were attributed to lipid 
peroxidation of highly unsaturated fatty acids.33 Large amounts of lipofuscin 
accumulate in the RPE of rats fed vitamin E deficient diets presumably through 
decreased absorption of disc membranes shed from the rod outer segments. 34 A 
study by Katz and Eldred did not support this role for vitamin E and tended to 
disqualify the hypothesis of light induced retinal damage via auto-oxidative 
mechanisms. Their study showed that vitamin E deficiency did not decrease the 
photoreceptor cell concentrations of rats exposed to cyclic light. Since the 
antioxidant effect of vitamin E has been well established, they concluded that cell 
damage to the retina following light exposure does not occur via an oxidative 
mechanism.35 
The following daily intakes of vitamin E are recommended by the 
Food and Nutrition Board of the National Research Councii.l7 
Age Daily Allowancel,2 
1-12 mos. 3-4 
1-7 yrs. 5-7 
8-18 yrs. 8 
Males 
19 yrs.+ 10 
Females 
19 yrs.+ 8 
Pregnant +2 
Lactating +3 
1. All units are mg. 
2. lmg of vitamin E equals 1 IU 
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Supplementing large quantities of vitamin E via oral intake appears to be of 
limited value. Supplementation of large doses has resulted in low systemic 
uptake with most of the vitamin excreted. This is a critical point when attempting 
to increase body supplies with oral tablets . 
Vitamin E toxicity will deplete vitamin A stores and doses exceeding 800 
mg./ day can alter immunity, impair sexual function, increase the risk of blood clot 
formation and change the metabolism of thyroid, pituitary and adrenal hormones. 
Additional side affects and adverse reactions include abdominal pain, breast 
enlargement, diarrhea, dizziness, headache, nausea and blurred vision.l7 
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MINERALS 
Minerals represent an important class of nutrients necessary for normal 
growth, development and metabolism. Although generally abundant in a healthy 
well rounded diet, evidence suggests people even within the U.S. population do 
not get adequate amounts of certain minerals. The Food and Drug Administration 
carried out a Total Diet Study during the early 1980's and found several age-sex 
groups were deficient in several of the eleven dietary essential minerals. Levels of 
calcium, zinc, iron, magnesium, copper and manganese were found to be less that 
80% of the RDA or below the low end of the Estimated Safe and Adequate Daily 
Dietary Intake range. The following groups were most at risk: 1) young children, 2) 
teenage girls, 3) adult women, and 4) older women.28 
Several minerals have important functions in ocular tissue changes and 
recent research tends to focus on zinc (Zn), copper (Cu) and selenium (Se). Similar 
to tissue changes associated with vitamin deficiency and toxicity/ significant and 
usually long term deviations from normal body mineral requirements are 
necessary before ocular tissue changes are seen. 
Calcium and Phosphorous 
Calcium concentrations are known to be higher in the cataractous lens but 
these increases were shown to occur after the opacification process has begun. 
Calcium deficiency that characterizes the systemic condition known as "rickets" 
has been associated with the onset of zonular and lamellar cataracts. Patients 
suffering from uncontrolled renal failure have been found to have calcium 
deposits in the conjunctiva and cornea. Such deposits are usually associated with 
high serum phosphorus levels. Hypercalcemia secondary to vitamin D 
intoxication has been shown to produce band keratopathy. Familial 
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hypophosphatemia has been the only condition directly attributed to phosphorus 
that results in significant tissue changes. Those changes include band keratopathy, 
conjunctiva calcification, orbital malformation, blue sclera, cataract, proptosis, and 
papilledema. 7 
Iron deficiency anemia has been associated with a pale conjunctiva, retinal 
hemorrhage, retinal edema, and arteriolar dilation. Choroidal and vitreal 
hemorrhage have been reported but are rare. Microvascular infarcts may result in 
cotton wool spots and exudates in the posterior pole. Papilledema resulting from 
chronic hypochromic microcytic anemia responds well to iron therapy . 
Iron toxicity can result in focal deposition of iron within tissue which is 
termed hemosiderosis. If tissue damage occurs, it is termed hemochromatosis. 
This condition is characterized by melanin deposition in the conjunctiva or lid 
margin. A golden-brown limbic ring similar to a Kayser-Fleischer ring has been 
reported in individuals on diets rich in iron. 7 
Zinc, Copper and Selenium 
These minerals are discussed simultaneously due to their interdependent 
nature. Zinc is the second most abundant trace element in the body. Enzyme 
functions that require Zn include carbonic anhydrase, superoxide dismutase, 
alkaline phosphatase, catalase and retinol dehydrogenase. Zinc is associated with 
melanin, proper immune function and facilitated uptake in the retinal pigment 
epithelium.36 Ocular tissues have been shown to have the highest concentration 
of Zn in the human body. Those Zn concentrations range from 600-800 ug/g of 
tissue. Rod cells and the choroid are two ocular tissues that contain significant 
amounts of Zn.37 Iris microcysts and degenerate retinal ganglion cells have been 
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found in individuals with Menke's kinky hair syndrome which is a sex-linked 
recessive disorder affecting copper absorption. Copper toxicity can lead to 
pathognomonic deposition of Cu in Descemet's membrane called Kayser-Fleischer 
ring. The radiating spokes of a sunflower cataract result from copper carbonate 
deposition on the anterior or posterior lens capsule? 
Recommended dietary allowances for Cu have not been set but safe 
intake estimates are listed below .17 
Age 
0-6 mos. 
6-12 mos. 
1-3 yrs. 
4-6 yrs. 
7-10 yrs. 
11 + yrs. 
Estimated Safe Intakel 
0.5-0.7 
0.7-1.0 
1.0-1.5 
1.5-2.0 
2.0-2.5 
2.0-3.0 
1) Intake units are mg/ day . 
Recent work has examined the potential role of Zn in retinochoroidal 
metabolism. Zinc deficiency has been found to impair dark adaptation. 
Supplemental zinc has been shown to improve rod function to normal with no 
simultaneous changes in serum vitamin A levels .38 One preliminary study 
indicated potential retardation of visual loss in a randomized group of patients 
with ophthalmoscopically visible macular degeneration following 
supplementation of 100 mg zinc sulfate twice daily.36 A potential weakness in 
this study lies in the failure to show a correlation between plasma zinc 
concentrations and visual acuity.39 Case reports also include the apparent success 
of intravenous Zn and selenium as a method of improving vision impairment 
secondary to macular degeneration. However, close review shows that other 
compounds were also included in the treatment regime including taurine, 
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vitamin E, anthocyanadin and Cinko Balboa.40 Elevated serum copper and zinc 
levels have been measured in patients with age related macular degeneration.41 
Symptoms of zinc toxicity at levels of 100-300 mg Zn/ d (vs RDA of 15 mg Zn/ d) 
include induced copper deficiency with symptoms of anemia and neutropenia, 
impaired immune function and altered LDL/ HDL ratios . 42 
Symptoms of Cu toxicity include nausea, vomiting, muscle aches, 
abdominal pain and anemia. 
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BOTANICAL PREPARATIONS 
Flayinoids 
Bioflavinoid, also known as vitamin P, is a biologically active flavin. These 
nitrogenous pigments can be called pyridine nucleotides. They function as 
coezymes to flavoproteins such as riboflavin. They provide active sites for 
oxidation reactions that produce free energy and eventually transfer electrons to 
02. They also supply active sites for electron transfer involving flavin adenine 
dinucleotide. 43 
Epicatechin and catechin are flavanols with glycoside forms. They are 
extracted from the bark of pterocarpus marsupium and known for their 
antioxidant role against hydroxyradical induced lipid peroxidation, a common 
threat to photoreceptor membrane function.44 These compounds are typically 
available by these same names in multivitamin/mineral supplements. 
Cinko is a bioflavone extracted from the leaves of the plant Cinko biloba. 
The active ingredients include three flavone glycosides (quercetrin, isorhamnetin 
and luteolin) and three bioflavones (ginkgetin, isoginkgetin and bilobetin). The 
product is marketed as Tebonin (Schwabe) and evidence shows these compounds 
improve blood flow in small arteries, capillary vessels and venoles.45 
Myrtillin is a compound extracted from the leaves of the blueberry (also 
known as bilberry) and was used in folk medicine for use in the treatment of 
diabetes mellitis. It is a glycoside that also contains anthocyanidin (blue pigment) 
which is a compound classified as a flavinoid. Myrtillin inhibits free radical 
damage, improves venous tone and capillary integrity . In Europe this compound 
has been used as an anti-hemorrhagic agent in the treatment of hypertensive and 
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diabetic retinopathy. Commercial claims include improved visual acuity due to 
myopia, presbyopia and eye fatigue. Dark adaptation can be improved through 
supplementation. Additional claims include retarded cataract development and 
decreased risk for glaucoma.44,45,46 The compound is marketed as a vision 
enhancer under the name Bilberry. 
Eyebright 
The herb Euphrasia officinalis is a remedy that is not taken as an oral 
supplement but was chosen to be included in this text because it is an herb 
specifically recommended for ocular problems. The whole plant is used and 
recommended as an effective compress for relief of redness, swelling, all 
conjunctivitis and blepharitis, and serpiginous corneal ulcers.45 
Vancamine 
Vancamine is extracted from the greater periwinkle, vinca major, in Europe 
and the Mediterranean countries. This botanical compound has been shown to 
increase circulation, specifically cerebral blood flow . Vancamine increases cerebral 
oxygen consumption and improves diffuse changes in electrical activity in the 
brain. Usually, recommended for cerebral arteriosclerosis and stroke sequelae, it is 
also reported to decrease dizziness associated with Meniere's syndrome and 
disorders of blood flow to the retina .45 
Pasque Flower 
The pasque flower of the genus/ species Pulsatilla vulgaris is used in both 
the whole plant form and as a plant extract. Both forms are prescribed as oral 
medication for iritis, scleritis, age related cataracts and glaucoma. 45 
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Barberry 
This compound is used as a tonic and is extracted from the plant Berberis 
vugaris. The active ingredient is berberine and is marketed as Opthiole (Mann) 
eyedrops purported to be effective against chronic and allergic conjunctivitis, lid 
inflammation and hypersensitive eyes.45 
B-carotene 
B-carotene a dietary essential element and is classified as a carotenoid. It is 
an orange/red pigment found in all plants where is absorbs blue light and 
functions to reduce the production of singlet oxygen in the chloroplast. Absorption 
from the intestine depends on the enzyme carotenase which cleaves the forty 
carbon aliphatic polyene chain molecule in half resulting in vitamin A. When 
absorbed intact from the digestive tract is has been shown to be an efficient 
quencher of singlet oxygen.S Structural characteristics favor its solubility in the 
cell lipid bilayer where photodynamic effects are preferentially situated.3 Some 
evidence suggests people with low tissue levels of B-carotene are prone to 
developing certain types of cancer.32 Tso found that a dietary supplement of B-
carotene reduced early photic damage of photoreceptors and retinal pigment 
epithelium in rats presumably through inhibition of photo-induced oxidative 
degradation. 23 Vitamin E has a sparing effect on B-carotene by inhibiting the 
oxidation of its multiple c-c double bonds.S 
B-carotene may play a role in delaying the development of cataracts. 
Epidemiological studies show patients with higher serum levels of B-carotene 
have decreased risk of developing cataracts. 20,38 Perhaps the ageing lens increases 
the demand for dietary antioxidants above the demand of a younger healthy 
individual. 
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OTHER POTENTIAL SUPPLEMENTS 
Glutathione 
Glutathione is a compound consisting of three amino acids- glycine, 
glutamic acid and cysteine. Glutathione (GSH) is found in high concentrations in 
the lens. Functioning as an antioxidant, it maintains reduced sulphur bonds with 
the lens proteins, acts as a coenzyme of various enzyme systems and participates in 
amino acid and mineral transport. GSH is diminished in all forms of cataracts. 
Levels can be increased by supplementing cysteine, glutamine and glycine. An 
ancient Chinese herbal formula "hachimijiogan" has been shown to increase 
glutathione levels and historically was used to slow the progression of cataracts. 46 
Superoxide Dismutase 
Superoxide dismutase (SOD) is an enzyme found in nearly all eucaryotic 
cells and it catalyzes the dismutase reaction:4 
OT + 02- + H2+ = H202 + 02 (ground state) 
It can be classified by its association with zinc (Zn) and copper (Cu). 
SOD plays a role in preventing oxidative damage by singlet oxygen in lens tissue 
which is thought to cause or at least accompany cataract progression.30 Ascorbic 
acid and glutathione tend to lower the activity of this enzyme in the human lens, 
but a progressive decrease in superoxide dismutase concentrations in the lens is 
encountered as cataracts develop. Oral supplementation seems to have little affect 
on tissue SOD activity since it is destroyed in the intestinal mucosa. However, 
Lane claims SOD is diet responsive although it is age indexed. He also suggests 
patients deficient in zinc and copper have lower SOD activity.47 SOD activity is 
very dependant on the trace metals copper, zinc and manganese. The trace metal 
cofactors act to stabilize the enzyme in vivo.46,4 
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Catalase 
Catalase is concentrated in the anterior portion of the lens and as in other 
cells and tissues it acts by catalyzing the reduction of hydrogen peroxide to oxygen 
and water.46 
Taurine 
Taurine (B-aminoethanesulfinic acid) is an amino acid that participates in 
few reactions but is found in most animal tissues with the highest concentrations 
in the muscle, platelets and developing central nervous tissue. There is evidence 
that it is synthesized by the body and appears to play a protective role against the 
cell membrane peroxidation.48 Taurine is the most abundant free amino acid in 
the retina where it is concentrated in the outer segments of rods and cones. Infants 
on long-term total parentral nutrition have been found to have lower plasma 
taurine levels. Electroretinograms of infants with low taurine levels have 
depressed a and b wave amplitudes which return to normal following 
intravenous taurine supplementation. These results support a role for taurine in 
retinal function and suggest this may also be an essential amino acid.49 
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DISCUSSION AND CONCLUSIONS 
There is considerable interest today in the role of nutritional supplements 
in the prevention, maintenance and treatment of ocular tissue changes. Decisions 
to prescribe these nutrient supplements for various ocular problems must be based 
on an understanding of their functions. This understanding must recognize the 
limits of our current knowledge. Prudent decisions regarding the use of 
nutritional supplements can be made by combining the "art" of optometric care 
with: 1) an understanding of the complexity of the visual system and 2) 
knowledge of early nutritional studies and current hypotheses. 
The eye is an organ composed of the numerous tissues that include bone, 
muscle, nervous, adipose, general and specialized connective tissues, glandular, 
epithelial and endothelial tissue. The blood and extracellular fluids support them. 
This tissue complex is organized into a functional system that lies in a delicate 
physiological balance with the rest of the body and the outside environment. The 
sensitive metabolic nature of these along with the importance of good vision 
emphasizes the need for long term healthy metabolic status that will support and 
protect this system from environmental and physiological stress encountered over 
a lifetime. 
Early research established specific roles for vitamins and minerals by placing 
experimental subjects on diets deficient in a specific nutrient. Gross signs and 
symptoms of deficiency were documented. Other studies determined the chemical 
analysis of each molecule, their metabolic roles and daily intake requirements 
based on metabolic demands for normal growth, maintenance, pregnancy and 
lactation. 
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Current investigations have looked at less obvious tissue changes that seem 
to be influenced by plasma and tissue concentrations of certain nutrients. 
Evidence shows cell and tissue damage may result from uncontrolled free radical 
initiated oxidation in tissues with high concentrations of fatty acids and oxygen 
which include the retina. Recent studies hypothesize increased tissue levels of 
certain nutrients with antioxidant properties such as b-carotene, vitamin E or 
bilberry could prevent and possible treat tissues damaged by uncontrolled 
oxidation processes. 
Vitamins, minerals, amino acids and other supplemental compounds play a 
pivotal role in ocular metabolism. As mentioned above, their previous value was 
measured on the basis of gross deficiency symptoms such the systemic problems 
common to the disease "scurvy" which results from a vitamin C deficiency. Gross 
clinical observations have been the foundation for diagnosing nutritional 
deficiency and toxicity symptoms involving the eye. Newer methods allow closer 
examination of less obvious forms of metabolic distress that produce adverse 
affects on ocular tissues. Early forms of metabolic stress appear related to metabolic 
demand and availability of dietary nutrients. Subclinical changes eventually lead 
to gross observable degenerative tissue changes. The role of a primary care 
provider should be to recognize the potential for early signs of degradable tissue 
changes and understand the use of nutritional aid. For example, the role of 
vitamin A today should be more than a preventative of night blindness and 
corneal xerosis which is seen only in cases of severe deficiency. These conditions 
are unlikely in modern cultures. However, evidence of a role for vitamin A in: 1) 
maintaining the secretory capacity of glands that contribute to the tear layer, 2) 
relieving punctate keratopathy, stromal infiltrates and neovascularization 
associated with corneal xerosis, and 3) reduction of the inflammatory response 
associated with corneal wound healing should be recognized as clear indicators of 
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its contribution to the general health of the cornea. Consequently, when the 
practitioner encounters patients exhibiting dry eye, corneal abrasions or perhaps 
epithelial complications associated with contact lens wear, the role of 
supplemental vitamin A should be considered. 
The "art" of a good optometric decision regarding the use of nutritional 
supplements must ultimately ask several critical questions and review available 
evidence. Several appropriate questions include: 
1) What is the goal- prevention or treatment? And, what is the evidence for 
each? 
2) What factors will influence the availability of the nutritional supplement in 
question? What is the bioavailability of a particular form? What are the levels 
of other nutrients in the diet and blood stream? 
3) What is the risk for toxicity? Does the patient have a systemic disease that 
could alter the therapuetic dose (kidney I liver or pancreas dysfunction, cystic 
fibrosis, hyperthyroid, intestinal problems such as diarrhea, peptic ulcer, gout, 
Parkinsons disease)? 
4) What effect will elevated amounts of a particular vitamin or mineral have 
on the bioavailability of other supplements? 
5) Will supplemented nutrients be stored, excreted or increase target tissue 
levels? 
6) Does the patient seem at risk of being deficient in a particular nutrient 
according to case history and lifestyle? 
The value of supplementation beyond current RDA is under question. Past 
methods of determining minimum daily requirements placed little emphasis on 
the potential for subclinical deficiencies in sensitive areas such as the visual 
system. They did not consider the possible benefits of higher doses to localized 
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tissues under metabolic stress. Many questions remain unanswered regarding the 
efficacy of supplementing vitamins, minerals and other compounds beyond the 
current recommended amounts as aid to specific tissLies. Several products such as 
Ocuvite or Bilberry are available and recommended for various ocular problems. 
However, the recommended doses have limited clinical support and some would 
argue the hypothesis for their use is also questionable. The functions of 
nutritional supplements are numerous and should play a larger role in decisions 
involving the health of ocular tissues. In the future, problems with dosages, 
interactions and efficacy should be examined vvith repeatable, controlled studies . 
Until that time, prudent use that considers the potential for toxicity should be of 
value to many patients. 
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DIRECTORY OF NUTRITIONAL SUPPLEMENT SUPPLIERS 
1. Amazon Herbs 
725 North Al-A Suite C 115 
Jupiter, Florida 
2. A yush Botanicals 
114 140th sw 
Everett WA 
3. Biological Homeopathic Industries, Inc. 
11600 Cochiti S.E. 
Albuquerque, NM 
4. Bio Active Nutritional 
1801 N. Wickhyam Road, Suite 2 
Melbourne, FL 
5. Boiron-Borneman 
1208 Amosland Rd. 
Norwood, PA 
6. Botanical Pharmaceuticals 
P.O. Box 3986 
West Sedona, AZ 
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11. Herb Pharm, Inc. 
P.O. Box 116-N 
Williams, OR 
12. NF Formulas 
805 S.E. Sherman 
Portland, OR 
13. Phyto-Pharmica 
P.O. 1745 
Green Bay, WI 
14. Progena 
2300 Louisiana N.E. 
Albuquerque, NM 
15. Scondinavia Pharmacueticals 
13 N . 7th St. 
Perkasie, P A 
16. Scientific Botanicals 
P.O. Box 20386 
Seattle, WA 
7. Doctor's Data 
P.O. Box 111 
Chicago, IL 
8. Eclectic Institute 
11231 SE Market St. 
Portland, OR 
9. Gaia Herbs 
62 Old Littleton Rd. 
Harvard, MA 
10. Great Smokies Diagnostic Lab 
18A Regent Park Blvd. 
Asheville, NC 
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17. Standard Homeopathies 
P.O. Box 61067 
Los Angeles, CA 
18. Thorne Research 
P.O. Box 3200 
Sandpoint, ID 
19. Tyler Encapsulations 
2200-4 NW Birdsdale 
Greshham, OR 
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